SITE MAP 
  HOME  
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
  JOBS  
  FREE SUBSCRIPTION  
  Tuesday, May 13, 2008 SEARCH     
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND

Australian Biotech and Pharmaceutical
PRIME NEWS
HealthLinx to begin marketing of OvPlex in Q3 2008
Melbourne based HealthLinx will begin marketing and distribution of OvPlex (Ovarian cancer diagnostic) in 3rd quarter 2008 with the claim that this is the accurate ovarian cancer diagnostic in the market
Prana discovers novel drug candidates for use in Parkinson's
A lead candidate drug has demonstrated positive effects in pre-clinical studies, protecting the brain from damage to the substantia nigra, the area of the brain affected in Parkinson's disease
TODAY'S NEWS
  Aurobindo Pharma to market 9 products in South Africa
  Spectrum Pharma sells injectable generic drugs to Sagent Pharma
  Merck, Schering-Plough present results of cholesterol drug
  Ranbaxy, Merck sign drug discovery, development agreement
  Over 1200 firms attend API & INTERPHEX China
  Helicon group secures China rights For Collatamp G
Advertisement
 
Digital Mag
Updated Fortnightly

Issue: April 30, 2008
Current Issue
View / Download
Top Story
China steps up the pace: India and China are racing to become lucrative pharmaceutical markets for global players
 
 
 
Print Edition
Issue: May 2008
Read Online
Free Subscription
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement





















 

NEWS
Helicon group secures China rights For Collatamp G
Australias Helicon group has said that it has acquired the exclusive licensing rights from EUSA Pharma to Collatamp G for the Chinese market
Starpharma reports positive VivaGel clinical study results
Australian pharma company Starpharma Holdings Limited has announced positive results of a clinical trial that achieved all its objectives
FEATURES
Australia's promising 3
BioSpectrum has named year 2008 as Year of the Entrepreneur. We are celebrating it by bringing you a series profiling entrepreneurs from the Asia Pacific region. The first in the series had three hot and happening companies from Singapore
Australia emerges as a global player
The Australian biotechnology sector has shown a robust growth. An exclusive report from AusBio 2007, Brisbane
PEOPLE
Avexa appoints Nathan Drona as non-executive director
Avexa, a biotechnology company focused on research and development of drugs for the treatment of infectious diseases has appointed Mr Nathan Drona a Non-Executive Director of the company
Ms Luana Staiger joins ChemGenex as VP, regulatory affairs
ChemGenex Pharmaceuticals, a pharmaceutical development company dedicated to improving the lives of patients by developing personalized oncology medicines from Australia has appointed Ms Luana Staiger as Vice President of Regulatory Affairs
EVENTS
Aus Biotech 2007 kicks off
Over 130 exhibitors from India, Italy, Korea, Malaysia, Japan, Taiwan and Canada are taking part in this mega biotechnology event of Australia
Brisbane to attract best in biotech for Aus Biotech 2007
Over 1200 delegates expected to attend the AusBiotech 2007 Conference to be held from October 21-24, 2007
R & D
CSIRO signs agreement with Oncaidia to develop anti-cancer drug
CSIRO, the Commonwealth Scientific and Industrial Research Organization, Australia's national science agency has entered into an agreement with Adelaide-based biotech company, Oncaidia, to make the company's new anti-cancer drug, Apomab, suitable for
Starpharma's SPL7013 indicates potential application for arthritis
Melbourne-based Starpharma has filed a patent application for the use of SPL7013, the active ingredient in VivaGel, to inhibit hyaluronidase activity in the treatment or prevention of a multiple diseases
POLICIES
IOC certifies Pharmaxis' aridol
The International Olympic Committee has included Australian firm Pharmaxis' aridol as an approved test for asthma in athletes competing in the Beijing Olympics
Australia announces changes to PBS for benefit of people
People with pleural mesothelioma, eye conditions, those who want to stop smoking and infants with chest infections will benefit from changes to the Pharmaceutical Benefits Scheme (PBS) that commence from January 1, 2008 in Australia
PRODUCTS
Millipore launches MultiScreenHTS+ filter plates
Millipore introduced the latest addition to the MultiScreen family of filter plates, the MultiScreenHTS+ for radiometric kinase and GPCR assays.
LabWare to launch WebLIMS 3 product suite
LabWare, a software development company focused exclusively on configurable Laboratory Information Management Systems (LIMS) will unveil its Next Generation WebLIMS 3 Product Suite this year. It is the latest product innovation from LabWare
TRENDS & ANALYSIS
Australia, New Zealand biotech companies performing well
Australian and New Zealand biotechnology companies are performing surprisingly well, despite low share prices, poor media interest and funding difficulties, according to a recent report by Innovation Dynamics
Over 450 drugs are in development stage by Australian companies
Over 450 drugs are currently in development by Australian biotechnology and pharmaceutical companies, with a significant number of compounds in advanced clinical trials
 
Advertisement





 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[CIOL Shop]  [DQ Channels]  [The DQweek]  [CyberMedia Dice]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black